Last reviewed · How we verify
vinflunine and best supportive care
vinflunine and best supportive care is a Anthracycline antibiotic Small molecule drug developed by Pierre Fabre Medicament. It is currently in Phase 3 development for Advanced or metastatic transitional cell carcinoma of the urothelial tract.
Vinflunine is a chemotherapeutic agent that works by intercalating DNA and inhibiting the enzyme topoisomerase II, thereby inducing apoptosis in cancer cells.
Vinflunine is a chemotherapeutic agent that works by intercalating DNA and inhibiting the enzyme topoisomerase II, thereby inducing apoptosis in cancer cells. Used for Advanced or metastatic transitional cell carcinoma of the urothelial tract.
At a glance
| Generic name | vinflunine and best supportive care |
|---|---|
| Sponsor | Pierre Fabre Medicament |
| Drug class | Anthracycline antibiotic |
| Target | Topoisomerase II |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
This results in the inhibition of cancer cell growth and proliferation. Vinflunine is a derivative of the anthracycline antibiotic doxorubicin and has been shown to have antitumor activity against various types of cancer.
Approved indications
- Advanced or metastatic transitional cell carcinoma of the urothelial tract
Common side effects
- Myelosuppression
- Nausea and vomiting
- Diarrhea
- Fatigue
- Anemia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- vinflunine and best supportive care CI brief — competitive landscape report
- vinflunine and best supportive care updates RSS · CI watch RSS
- Pierre Fabre Medicament portfolio CI
Frequently asked questions about vinflunine and best supportive care
What is vinflunine and best supportive care?
How does vinflunine and best supportive care work?
What is vinflunine and best supportive care used for?
Who makes vinflunine and best supportive care?
What drug class is vinflunine and best supportive care in?
What development phase is vinflunine and best supportive care in?
What are the side effects of vinflunine and best supportive care?
What does vinflunine and best supportive care target?
Related
- Drug class: All Anthracycline antibiotic drugs
- Target: All drugs targeting Topoisomerase II
- Manufacturer: Pierre Fabre Medicament — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Advanced or metastatic transitional cell carcinoma of the urothelial tract
- Compare: vinflunine and best supportive care vs similar drugs
- Pricing: vinflunine and best supportive care cost, discount & access